<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Therapy</journal-id><journal-title-group><journal-title xml:lang="en">Therapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапия</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2412-4036</issn><issn publication-format="electronic">2713-1823</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">626131</article-id><article-id pub-id-type="doi">10.18565/therapy.2023.9.70-78</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Role of visceral obesity in the progression of main arteries rigidity in chronic heart failure patients</article-title><trans-title-group xml:lang="ru"><trans-title>Роль висцерального ожирения в прогрессировании ригидности магистральных артерий у больных хронической сердечной недостаточностью</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3306-0312</contrib-id><name-alternatives><name xml:lang="en"><surname>Statsenko</surname><given-names>Mikhail E.</given-names></name><name xml:lang="ru"><surname>Стаценко</surname><given-names>Михаил Евгеньевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Professor, Vice-Rector for Research Work, Head of the Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, проректор по научной работе, зав. кафедрой внутренних болезней</p></bio><email>mestatsenko@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6232-4583</contrib-id><name-alternatives><name xml:lang="en"><surname>Derevyanchenko</surname><given-names>Maria V.</given-names></name><name xml:lang="ru"><surname>Деревянченко</surname><given-names>Мария Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Professor of the Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры внутренних болезней </p></bio><email>derevjanchenko@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5736-2235</contrib-id><name-alternatives><name xml:lang="en"><surname>Fabritskaya</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Фабрицкая</surname><given-names>Светлана Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Medical Sciences, Associate Professor of the Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры внутренних болезней </p></bio><email>lanabelenkova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9351-3002</contrib-id><name-alternatives><name xml:lang="en"><surname>Ryndina</surname><given-names>Yulia A.</given-names></name><name xml:lang="ru"><surname>Рындина</surname><given-names>Юлия Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student of the Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>аспирант кафедры внутренних болезней </p></bio><email>rindina91@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9016-3011</contrib-id><name-alternatives><name xml:lang="en"><surname>Streltsova</surname><given-names>Anastasia M.</given-names></name><name xml:lang="ru"><surname>Стрельцова</surname><given-names>Анастасия Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant at the Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>ассистент кафедры внутренних болезней </p></bio><email>nastyc03@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volgograd State Medical University of the Ministry of Healthcare of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2023</year></pub-date><volume>9</volume><issue>9</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>70</fpage><lpage>78</lpage><history><date date-type="received" iso-8601-date="2024-01-27"><day>27</day><month>01</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-01-27"><day>27</day><month>01</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, ООО «Бионика Медиа»</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2412-4036/article/view/626131">https://journals.eco-vector.com/2412-4036/article/view/626131</self-uri><abstract xml:lang="en"><p>Obesity is one of the leading risk factors for chronic heart failure (CHF) development and progression.</p> <p><bold>The aim: </bold>to estimate the role of visceral obesity in the progression of rigidity of main arteries in CHF patients.</p> <p><bold>Material and methods. </bold>165 patients with CHF stages I–IIA, FC I–III, aged 40–65 years were examined. They were randomized into three groups: 1st – with CHF and normal BMI (n=55), 2nd – with CHF and excess BMI (n=53), 3rd – with CHF and obesity of 1–2nd degree (n=57). Patients underwent a clinical examination, BMI calculation, measurements of waist circumference (WC), hip circumference (HC), waist/hip width measurement, bioimpedance measurements, also thickness of epicardial adipose tissue (EAT) was assessed using EchoCG, pulse wave velocity through elastic and muscular vessels (PWVe and PWVm), serum levels of leptin and adiponectin were identified.</p> <p><bold>Results.</bold> A high incidence of abdominal obesity, an increase in visceral fat content and an increase in EAT thickness among patients with excess BMI and obesity were revealed. In the group of patients with CHF and obesity, PWVe was significantly higher – 10,8 [9,2; 12,9] m/s. In group 3, patients with PWVe &gt;10 m/s were significantly more common – 82% versus 57% and 65% in groups 1 and 2, respectively. Significant correlations were established between PWVe and WC (r=0,42), WC/HC (r=-0,44), PWVe and BMI (r=0,38), PWWm and WC (r=0,40), PWWm and WC/TB (r=-0,42), PWWm and BMI (r=0,32) among patients with CHF and obesity. When assessing the dependence of PWVe on the percentage of visceral fat and PWEv on the thickness of EAT, a linear regression dependence and a high-close correlation were obtained. In the 3rd group, statistically significant correlations were revealed between PWVe and the concentration of leptin and (r=0,58), PWVe and the level of adiponectin (r=-0,76). A statistically significant correlation was found between EAT thickness and leptin level (r=0,62), EAT thickness and adiponectin level (r=-0,56).</p> <p><bold>Conclusion. </bold>Reliable associations between the severity of visceral obesity and indexes of vascular wall elasticity reflect the important pathogenetic role of visceral adipose tissue in the development and progression of arterial stiffness in patients with CHF.</p></abstract><trans-abstract xml:lang="ru"><p>Ожирение – один из ведущих факторов риска развития и прогрессирования хронической сердечной недостаточности (ХСН).</p> <p><bold>Цель</bold> – оценить роль висцерального ожирения в прогрессировании ригидности магистральных артерий у больных ХСН.</p> <p><bold>Материал и методы. </bold>Обследованы 165 пациентов с ХСН I–IIА стадии, I–III ФК в возрасте 40–65 лет, рандомизированные на три группы: 1-я – с ХСН и нормальным ИМТ (n=55), 2-я – с ХСН и избыточным ИМТ (n=53), 3-я – с ХСН и ожирением 1–2-й степени (n=57). Пациентам проводилось клиническое обследование, расчет ИМТ, замеры окружности талии (ОТ), бедер (ОБ), определение ОТ/ОБ, биоимпедансометрия, оценивалась толщина эпикардиальной жировой ткани (ЭЖТ) с помощью ЭхоКГ, скорость распространения пульсовой волны по сосудам эластического и мышечного типа (СРПВэ и СРПВм), определялся сывороточный уровень лептина и адипонектина.</p> <p><bold>Результаты.</bold> Выявлена высокая частота встречаемости абдоминального ожирения, увеличение содержания висцерального жира и возрастание толщины ЭЖТ среди больных, имеющих избыточный ИМТ и ожирение. В группе больных с ХСН и ожирением достоверно выше была СРПВэ – 10,8 [9,2; 12,9] м/с. В 3-й группе достоверно чаще встречались пациенты с СРПВэ &gt;10 м/с – 82 против 57 и 65% в 1-й и 2-й группах соответственно. Установлены достоверные корреляционные связи между СРПВэ и ОТ (r=0,42), ОТ/ОБ (r=-0,44), СРПВэ и ИМТ (r=0,38), СРПВм и ОТ (r=0,40), СРПВм и ОТ/ОБ (r=-0,42), СРПВм и ИМТ (r=0,32) среди пациентов с ХСН и ожирением. При оценке зависимости СРПВэ от процента висцерального жира и СРПВэ от толщины ЭЖТ получена линейная регрессионная зависимость и корреляционная связь высокой тесноты. В 3-й группе выяввлены статистически значимые связи между СРПВэ и концентрацией лептина и (r=0,58), СРПВэ и уровнем адипонектина (r=-0,76). Обнаружена статистически значимая связь между толщиной ЭЖТ и уровнем лептина (r=0,62), толщиной ЭЖТ и уровнем адипонектина (r=-0,56).</p> <p><bold>Заключение.</bold> Достоверные ассоциации между степенью выраженности висцерального ожирения и показателями эластичности сосудистой стенки отражают важную патогенетическую роль висцеральной жировой ткани в развитии и прогрессировании ригидности артерий у больных с ХСН.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic heart failure</kwd><kwd>visceral obesity</kwd><kwd>epicardial adipose tissue</kwd><kwd>arterial rigidity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>висцеральное ожирение</kwd><kwd>эпикардиальная жировая ткань</kwd><kwd>ригидность артерий</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(11): 311–374. [Clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(11): 311–374 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2020-4083. EDN: LJGGQV.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Гриценко О.В., Чумакова Г.А., Шевляков И.В., Трубина Е.В. Механизмы развития сердечной недостаточности при ожирении. Российский кардиологический журнал. 2018; 23(5): 81–86. [Gritsenko О.V., Chumakova G.А., Shevlyakov I.V., Trubina Е.V. The mechanisms of heart failure development in obesity. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 23(5): 81–86 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2018-5-81-86. EDN: XOTJHF.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Гиоева З.М., Богданов А.Р., Залетова Т.С., Богданова А.А. Ожирение как фактор риска развития хронической сердечной недостаточности (литературный обзор). Доктор.Ру. 2017; (10): 21–25. [Gioeva Z.M., Bogdanov A.R., Zaletova T.S., Bogdanova A.A. Obesity as a risk factor for chronic heart failure: A review of the literature. Doctor.Ru. 2017; (10): 21–25 (In Russ.)]. EDN: ZXWOHX.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Попова И.Р., Драпкина О.М. Роль ожирения в развитии хронической сердечной недостаточности. Лечебное дело. 2012; (3): 68–73. [Popova I.R., Drapkina O.M. Obesity and chronic heart failure. Lechebnoe delo = General Medicine. 2012; (3): 68–73 (In Russ.)]. EDN: THQLUB.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Драпкина О.М., Дадаева В.А. Жесткость сосудистой стенки при хронической сердечной недостаточности. Клиницист. 2013; 7(3–4): 27–30. [Drapkina O.M., Dadaeva V.A. Vascular stiffness in heart failure. Klinitsist = The Сlinician. 2013; 7(3–4): 27–30 (In Russ.)]. EDN: SHUGOT.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Yildiran T., Koc M., Bozkurt A. et al. Low pulse pressure as a predictor of death in patients with mild to advanced heart failure. Tex Heart Inst J. 2010; 37(3): 284–90.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Feola M., Testa M., Ferreri C. et al. The analysis of arterial stiffness in heart failure patients in comparison with healthy subjects and patients with cardiovascular risk factors. J Clin Med. 2019; 8(10): 1721. https://dx.doi.org/10.3390/jcm8101721.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Anastasio F., Testa M., Ferreri C. et al. The analysis of arterial stiffness in heart failure patients: The prognostic role of pulse wave velocity, augmentation index and stiffness index. J Clin Med. 2022; 11(12): 3507. https://dx.doi.org/10.3390/ jcm11123507.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kim H.L., Ahn D.W., Kim S.H. et al. Association between body fat parameters and arterial stiffness. Sci Rep. 2021; 11(1): 20536. https://dx.doi.org/10.1038/s41598-021-00175-z.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Дружилова О.Ю., Дружилов М.А., Кузнецова Т.Ю. Прогностическое значение показателей артериальной жесткости при оценке кардиометаболического риска у пациентов с ожирением. Российский кардиологический журнал. 2018; 23(5): 15–20. [Druzhilova O.Yu., Druzhilov M.A., Kuznetsova T.Yu. Predictive significance of arterial stiffness parameters in evaluation of cardiometabolic risk in obesity patients. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 23(5): 15–20 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2018-5-15-20. EDN: XOTJED.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Para I., Albu A., Porojan M.D. Adipokines and arterial stiffness in obesity. Medicina (Kaunas). 2021; 57(7): 653. https://dx.doi.org/10.3390/medicina57070653.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Клинические рекомендации. Ожирение. Российская ассоциация эндокринологов, Общество бариатрических хирургов. Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 28. Доступ: https://cr.minzdrav.gov.ru/schema/28_2 (дата обращения – 01.11.2023). [Clinical guidelines. Obesity. Russian Association of Endocrinologists, Society of Bariatric Surgeons. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 28. URL: https://cr.minzdrav.gov.ru/schema/28_2 (date of access – 01.11.2023) (In Russ.)].</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А. с соавт. Ожирение. Consilium Medicum. 2021; 23(4): 311–325. [Dedov I.I., Mokrysheva N.G., Mel’nichenko G.A. et al. Obesity. Consilium Medicum. 2021; 23(4): 311–325 (In Russ.)]. https://dx.doi.org/10.26442/20751753.2021.4.200832. EDN: GYUVLJ.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Шляхто Е.В., Недогода С.В., Конради А.О. Национальные клинические рекомендации «Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний». СПб. 2017; с. 1–164. [Shlyakhto E.V., Nedogoda S.V., Konradi A.O. National clinical guidelines «Diagnostics, treatment, prevention of obesity and associated diseases». Saint Petersburg. 2017; pp. 1–164 (In Russ.)].</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Amato M.C., Giordano C., Galia M. et al. Visceral adiposity index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4): 920–22. https://dx.doi.org/10.2337/dc09-1825.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Драпкина О.М., Корнеев О.Н., Драпкина Ю.С. Эпикардиальный жир: нападающий или запасной? Рациональная фармакотерапия в кардиологии. 2013; 9(3): 287–291. [Drapkina O.M., Korneeva O.N., Drapkina Yu.S. Epicardial fat: A striker or a spare? Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2013; 9(3): 287–291 (In Russ.)]. https://dx.doi.org/10.20996/1819-6446-2013-9-3-287-291. EDN: QIKZSH.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Чумакова Г.А., Веселовская Н.Г., Козаренко А.А. с соавт. Эпикардиальное жировое депо: морфология, диагностика, клиническое значение. Сердце: журнал для практикующих врачей. 2011; 10(3): 146–150. [Chumakova G.А., Veselovskaya N.G., Kozarenko А.А. Epicardial fat depot: Morphology, diagnosis, clinical significance. Serdtse: zhurnal dlya praktikuyushchikh vrachey = Heart: Journal for Medical Practitioners. 2011; 10(3): 146–150 (In Russ.)]. EDN: OZDSPT.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gonzalez N., Moreno-Villegas Z., Gonzalez-Bris A. et al. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017; 16(1): 44. https://dx.doi.org/10.1186/s12933-017-0528-4.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Christensen R.H., von Scholten B.J., Lehrskov L.L. et al. Epicardial adipose tissue: An emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metab. 2020; 11: 2042018820928824. https://dx.doi.org/10.1177/2042018820928824.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hendricks S., Dykun I., Balcer B. et al. Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction - a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study. Medicine (Baltimore). 2021; 100(52): e28060. https://dx.doi.org/10.1097/MD.0000000000028060.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Sato F., Maeda N., Yamada T. et al. Association of epicardial, visceral, and subcutaneous fat with cardiometabolic diseases. Circ J. 2018; 82(2): 502–8. https://dx.doi.org/10.1253/circj.CJ-17-0820.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Natale F., Tedesco M.A., Mocerino R. et al. Visceral adiposity and arterial stiffness: Echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr. 2009; 10(4): 549–55. https://dx.doi.org/10.1093/ejechocard/jep002.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Juge-Aubry C.E., Henrichot E., Meier C.A. Adipose tissue: A regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005; 19(4): 547–66. https://dx.doi.org/10.1016/j.beem.2005.07.009.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Engin A. Adiponectin-resistance in obesity. Adv Exp Med Biol. 2017; 960: 415–41. https://dx.doi.org/10.1007/978-3-319-48382-5_18.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Youn J.C., Kim C., Park S. et al. Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol. 2013; 163(3): 316–19. https://dx.doi.org/10.1016/j.ijcard.2011.06.061.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zachariah J.P., Hwang S., Hamburg N.M. et al. Circulating adipokines and vascular function: Cross-sectional associations in a community-based cohort. Hypertension. 2016; 67(2): 294–300. https://dx.doi.org/10.1161/hypertensionaha.115.05949.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Nakamura K., Fuster J.J., Walsh K. Adipokines: A link between obesity and cardiovascular disease. Cardiol. 2014; 63(4):250–59. https://dx.doi.org/10.1016/j.jjcc.2013.11.006.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Windham B.G., Griswold M.E., Farasat S.M. et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens. 2010; 23(5): 501–7. https://dx.doi.org/10.1038/ajh.2010.8.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Stork S., Bots M.L., Angerer P. et al. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis. 2007; 194(2): e147–53. https://dx.doi.org/10.1016/j.atherosclerosis.2006.11.044.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Martinez-Martinez E., Miana M., Jurado-Lopez R. The potential role of leptin in the vascular remodeling associated with obesity. Int J Obes (Lond). 2014; 38(12): 1565–72. https://dx.doi.org/10.1038/ijo.2014.37.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Wu Q., Chen Y., Chen S. et al. Correlation between adiponectin, chemerin, vascular endothelial growth factor and epicardialfat volume in patients with coronary artery disease. Exp Ther Med. 2020; 19(2): 1095–102. https://dx.doi.org/10.3892/etm.2019.8299.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kim B.J., Kim B.S., Kang J.H. Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol. 2013; 167(5): 2234–38. https://dx.doi.org/10.1016/j.ijcard.2012.06.013.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Korkmaz L., Cirakoglu O.F., Agac M.T. et al. Relation of epicardial adipose tissue with arterial compliance and stiffness in patients with hypertension. Angiology. 2014; 65(8): 691–95. https://dx.doi.org/10.1177/0003319713502120.</mixed-citation></ref></ref-list></back></article>
